Monitoring of CMV‐specific cell‐mediated immunity with a commercial ELISA‐based interferon‐γ release assay in kidney transplant recipients treated with antithymocyte globulin-Reference-Cited by-同舟云学术

Monitoring of CMV‐specific cell‐mediated immunity with a commercial ELISA‐based interferon‐γ release assay in kidney transplant recipients treated with antithymocyte globulin

Published:2020-02-21 Issue:8 Volume:20 Page:2070-2080
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:Am J Transplant

Author:

Fernández‐Ruiz Mario¹^ORCID,Rodríguez‐Goncer Isabel¹,Parra Patricia¹,Ruiz‐Merlo Tamara¹,Corbella Laura¹,López‐Medrano Francisco¹,Polanco Natalia²,González Esther²,San Juan Rafael¹^ORCID,Folgueira María Dolores³,Andrés Amado²^ORCID,Aguado Jose María¹

Affiliation:

1. Unit of Infectious Diseases Hospital Universitario "12 de Octubre" Instituto de Investigación Sanitaria Hospital "12 de Octubre" (imas12) Madrid Spain

2. Department of Nephrology Hospital Universitario "12 de Octubre" Instituto de Investigación Sanitaria Hospital "12 de Octubre" (imas12) Madrid Spain

3. Department of Microbiology Hospital Universitario "12 de Octubre" Instituto de Investigación Sanitaria Hospital "12 de Octubre" (imas12) Madrid Spain

Funder

Fundación Mutua Madrileña

Instituto de Salud Carlos III

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajt.15793

Reference27 articles.

1. Cytomegalovirus in solid organ transplant recipients—Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice

2. State-of-the-Art Monitoring of Cytomegalovirus-Specific Cell-Mediated Immunity After Organ Transplant: A Primer for the Clinician